相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of multidrug resistance-conferring mutations on the fitness and virulence of Pseudomonas aeruginosa
Kamilia Abdelraouf et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Treatment Outcome and Mortality among Patients with Multidrug-resistant Tuberculosis in Tuberculosis Hospitals of the Public Sector
Doo Soo Jeon et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2011)
Fitness Cost of VanA-Type Vancomycin Resistance in Methicillin-Resistant Staphylococcus aureus
Marie-Laure Foucault et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Spontaneous deletion of the methicillin resistance determinant, mecA, partially compensates for the fitness cost associated with high-level vancomycin resistance in Staphylococcus aureus
Michael J. Noto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Pharmacodynamic Modeling of Aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: Identifying Dosing Regimens To Suppress Resistance Development
Vincent H. Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
The impact of multidrug resistance on the outcomes of critically ill patients with Gram-negative bacterial pneumonia
Andrea L. H. Kwa et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae
Daniel E. Rozen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The biological cost of mutational antibiotic resistance: any practical conclusions?
Dan I. Andersson
CURRENT OPINION IN MICROBIOLOGY (2006)
In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance
N. McCallum et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Mutations conferring aminoglycoside and spectinomycin resistance in Borrelia burgdorferi
D Criswell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence
AJ O'Neill et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections
PK Lindgren et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Rifampicin resistance and its fitness cost in Enterococcus faecium
VI Enne et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Fitness of antibiotic resistant Staphylococcus epidermidis assessed by competition on the skin of human volunteers
I Gustafsson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Fitness cost of chromosomal drug resistance-conferring mutations
P Sander et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance
J Björkman et al.
SCIENCE (2000)
分享论文
